BPH Flashcards
Prostate is derivation of ____derm
endoderm
____ zone is site of BPH
Transitional (encircles urethra)
____ zone is site of prostate ca.
Peripheral (75% of gland)
BPH is cellular proliferation of ____ and ____ parts
stromal & epithelial
alpha-1 blockers inhibit prostate _____ and decrease prostatic urethral resistance
smooth muscle contraction
LUTS work-up
History
Exam
_____ symptom score
Lab test: ____
AUA-SS
UA
Prior to BPH surgery….
Size evaluation with ___, ____, or ___
Voiding studies - ____ & ____
U/S, cystoscopy, or cross-sectional imaging
PVR & Uroflow
1st Line BPH therapies
- Fluid restriction prior to sleeping
- Limiting alcohol and caffeine
- Voiding diary with frequency-volume chart
- Timed voiding
- Double voiding
- Bladder training
- Avoiding constipation
Alpha-blocker side effects
Adverse effects
• Dizziness (orthostasis)
• Retrograde ejaculation (6%)
• Rhinitis (12%)
• Intraoperative floppy iris syndrome (IFIS)
• higher rates of iris trauma and posterior capsule rupture during cataract surgery with ANY use of Tamsulosin
____ has the least risk of ejaculatory dysfunction of all alpha-blockers
Alfuzosin (Uroxatral)
5-ARIs have maximal prostate size reduction after ___ with an average size reduction of ___ %
6 months… 15-30%
Finasteride also suppresses _____ which makes it useful in men with refractory hematuria 2/2 prostatic bleeding
VEGF
Risk reduction of retention or prostate surgery with Finasteride use is ___%
70%
____ medications work by relaxing detrusor muscle to increase bladder storage volumes and decrease sensation for micturition
Beta-3 agonists (Mirabegron)
Side effects of Mirabegron
HTN(7.3%), Nasopharyngitis (3.4%)
PDE-5i with FDA approval for daily use in men with BPH/LUTS
Tadalafil 5 mg (Cialis)
Side effcts of PDE-5i
Headache (15%)
Facial flushing (4-10%)
Dyspepsia (3-11%)
Mechanism of PDE-5i
block breakdown of cGMP to GMP by phosphodiesterase leading to vasodilation
MTOPS study
Compared ___, ____, ___, ____
Results: ____ AUR, BPH surgery, BPH progression
placebo vs doxazosin vs finasteride vs combo
REDUCED aur, bph sx, bph progression
COMBAT trial
Compared ____ vs ____ vs ____
Results: ___ Qmax, PSA, & prostate volume
Tamsulosin vs Dutasteride (Avodart) vs combo
TIMES Trial
Compared ____ vs _____
Results: ____ nocturia, frequency/urgency, ____ in Qmax, PVR
Tolteroderine (Detrol) vs Detrol + Flomax
Improved symptoms
No change in Qmax or PVR
PLUS trial
Compared ____ vs ____
Results: ____ mean volume voided per micturition, & urgency and frequency, ____ in Qmax or PVR, ____
retention rates in the tamsulosin plus mirabegron group
Flomax vs Flomax + Mirabegron
Improved volume & urgency & frequency
No change in Qmax or PVR
Higher retention rates in combo group
Indications for BPH Surgery
Refractory to and/or unwilling to use other therapies Renal insufficiency secondary to BPH Urinary retention secondary to BPH Recurrent UTI Recurrent bladder stones Gross hematuria secondary to BPH
Urolift contraindications
Size >___ cc
Prominent ____ lobe
> 80 cc
Prominent middle lobe
Water Vapor Therapy (Rezum) Mechanism
Water vapor energy leads to disruption of cell membranes and tissue necrosis
AUA Guideline: PAE is ___ recommended for the treatment of LUTS/BPH outside the context of a clinical trial
NOT
AUA Guideline: PAE is ___ recommended for the treatment of LUTS/BPH outside the context of a clinical trial
NOT
What challenges are involved in the medical management of BPH in elderly men?
Multiple comorbidities, polypharmacy, adverse effects, drug-drug interactions, limited data on medications for those over 80, and specific concerns regarding alpha blockers.
What is FORTA classification, and how is it used in treating BPH in elderly men?
FORTA (Fit fOR The Aged) classification categorizes the safety and efficacy of medications for BPH in men over 65. It helps in selecting the right medication, considering factors like side effects and interactions.
What are the key considerations in using alpha blockers in the management of BPH in elderly patients?
Alpha blockers like alfuzosin, doxazosin, tamsulosin, and silodosin are commonly used. Considerations include FORTA classification, side effects like orthostatic hypotension, intraoperative floppy iris syndrome (IFIS), interaction with cataract surgery, and sexual side effects.
Figure. Treatment algorithm for the elderly male with BPH. OAB, overactive bladder. OSA, obstructive sleep apnea
What factors must be considered for an individualized approach to BPH in men over 80?
Comorbidities, operative risk, polypharmacy, living environment, resources, and mental acuity.
Why is understanding the living environment crucial in older patients with BPH?
To assess toileting abilities, fall risks, caregiver support, and choose the best treatment path.
What diagnostic tools are important in understanding BPH issues in older men?
Voiding diaries, urodynamics, cystoscopy.
What is the typical first-line therapy for BPH?
Medications, considering comorbidities, polypharmacy, and the FORTA classification.
What should be considered when prescribing alpha blockers for BPH in the elderly?
Side effects like orthostatic hypotension, IFIS, and QTc prolongation. Only silodosin and tamsulosin are acceptable in the FORTA classification.
What are the advantages and classification of 5ARIs in BPH treatment for the elderly?
Reduction of prostate volume, lack of adverse cognitive and cardiovascular effects, 3-4 months for symptom change, FORTA B classification.
What is the role of PDE-5s in BPH treatment?
Treats both LUTS and ED, tadalafil FDA-approved for daily use, FORTA-C classification.
What is the role and considerations of anticholinergics in BPH treatment for the elderly?
Reduces nerve impulses in bladder muscles, significant side effects in some types, fesoterodine preferred, FORTA classification varies.
Describe the role and effects of beta-3 agonists like mirabegron in BPH treatment.
Causes detrusor relaxation, well-tolerated with low adverse effects, hypertension, and urinary tract infection as common effects.
What are the combination therapies for BPH, and how effective are they?
Alpha Blocker and 5-ARI, Alpha Blocker and Anticholinergic; effective in reducing symptoms and progression.
What are the roles of testosterone replacement and antiandrogens in BPH treatment?
Testosterone improves quality of life but risks prostate growth (mitigated with 5ARIs); antiandrogens for rapid reduction in prostate size.
What are the special considerations for elderly patients undergoing BPH surgery?
Anesthetic risks, polypharmacy, anticoagulation, comorbidities, social factors, recovery components, frailty, and potential catheter use.
What are MISTs, and what makes them attractive for frail men?
Low-risk office-based procedures like prostatic urethral lift, water vapor thermotherapy; may require anesthesia or sedation. Advantages and disadvantages listed in table 3.
How is PAE used in BPH treatment, especially for frail older men?
Reasonable and safe treatment, beneficial for refractory/recurrent hematuria, concerns about contrast load and prolonged treatment times.
What are the key considerations regarding anesthesia in elderly BPH surgery?
Hemodynamic and cognitive risks, limiting duration, regional approaches, risk of neurotoxicity, pressure ulcers, limited mobility, and traumatic fractures.
What are the surgical approaches and potential modifications for elderly BPH patients?
: Avoiding monopolar TUR, laparoscopic, robotic, and open surgery; preferring laser procedures; modifying techniques like channel bipolar TUR; considering short-term hormonal therapy for untreated prostate cancer.
What are the critical postoperative considerations for elderly men after BPH surgery?
Managing fluid intake, constipation, voiding symptoms, recurrent hematuria, potential catheter or suprapubic tube trials, antibiotics, consideration of 5ARIs or antiandrogens.
What is the importance of assessing frailty in elderly patients undergoing BPH surgery?
Increased risk of complications, length of hospital stay, mortality; assessment tools like frailty phenotype and frailty index; lack of consensus on optimization; geriatric assessment advised.
What are the concluding thoughts on treating BPH in older men?
Requires full assessment and thoughtful approach, considering voiding issues, treatment risks, patient frailty, living environment; tailored treatment options with multiple choices.
What is the FORTA classification system for medical therapies used to treat BPH in men ≥65, and how are the medications classified?
FORTA A (Absolutely): None
FORTA B (Beneficial): Dutasteride, Finasteride (5ARI); Fesoterodine, Oxybutynin extended release, Solifenacin, Tolterodine, Trospium (Anticholinergic); Tadalafil (Phosphodiesterase inhibitor)
FORTA C (Careful/Caution): Darifenacin, Mirabegron (Anticholinergic); Alfuzosin, Doxazosin, Silodosin, Tamsulosin, Terazosin (Alpha blocker)
FORTA D (Do Not Recommend): Oxybutynin immediate release (Anticholinergic); Propiverine (Anticholinergic)
What are the advantages and disadvantages of MIST procedures in treating BPH?
Advantages:
Office setting performance
Sedation options for those intolerant to local anesthesia
Fast procedures in experienced hands (e.g., prostatic urethral lift, water vapor thermotherapy)
No tissue removal (prevents sloughing or delayed complications)
No sexual side effects
Some therapies repeatable (e.g., water vapor thermotherapy, transurethral microwave therapy)
What are the advantages and disadvantages of MIST procedures in treating BPH?
May not sufficiently improve symptoms
Prolonged treatment time for awake patients (e.g., transurethral microwave therapy)
Delayed symptom resolution due to lack of tissue removal
Utility in large prostates unproven for most methods
Potential post-procedure hematuria
Prostatic edema may require prolonged catheterization
May not be suitable or efficacious with middle lobes
Uncertain long-term durability in large prostates or those with a middle lobe
What are the side effects and risks of Alpha Blockers in the treatment of BPH in elderly patients?
Orthostatic hypotension
Retrograde ejaculation
Rhinitis
Risk for IFIS
QTc prolongation
CHF exacerbation in selective patients
What are the side effects and risks of Beta 3 Agonists in the treatment of BPH in elderly patients?
Hypertension
Cardiac arrhythmias
Dizziness
Headache
Constipation
Infections (e.g., cystitis, pharyngitis)
What are the side effects and risks of PDE-5 Inhibitors in the treatment of BPH in elderly patients?
Headache
Dyspepsia
Nasopharyngitis
Back pain
Cardiovascular effects
Dizziness
Hypotension
What are the side effects and risks of 5ARIs in the treatment of BPH in elderly patients?
Altered sexual function
Reduction of sexual libido
ED
Gynecomastia (no association with male breast cancer)
What are the side effects and risks of Anticholinergics in the treatment of BPH in elderly patients?
Dry eyes and mouth
Blurred vision
Constipation
Fever
Flushing
Tachycardia
QT prolongation
Urinary retention
Psychosis/confusion
Sex accessory tissues include the :(4)
They are believed to play a major, but unknown, role in the reproductive process
Sex accessory tissues include the prostate gland, seminal vesicles, ampullae, and bulbourethral glands. They are believed to play a major, but unknown, role in the reproductive process